“I, Ovosan” offers inspiring cancer survivor stories interwoven with cutting-edge research, detailing the development and therapeutic potential of Ovosan’s bioactive phospholipids, now available in the US as CellBB. AURORA, Colo., April 3, 2025 /PRNewswire/ — Immod is thrilled to…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.